EMNC yields 200000000.00% · PFE yields 6.13%● Live data
📍 EMNC pulled ahead of the other in Year 1
Combined, EMNC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EMNC + PFE for your $10,000?
E-Monee.com, Inc develops and operates secure payment solutions that collect, manage, and disburse funds to corporate, financial, and consumer markets worldwide. It offers e-payroll program, an end-to-end electronic payroll solution that provides various financial solutions for the employer and employee; commission and vendor e-payments program, which enables companies to centralize the development of financial transactions into one mechanism; and gift/prepaid card programs. The company also provides banking financial solutions using its pre-paid processing platform that offers sales, marketing, and customer support, as well as accounts management. In addition, it offers electronic payment solutions, card issuing and processing systems, payroll solutions, virtual banking solutions, ATM solutions, point of service solutions, customer service support and solutions, fraud management and filtering solutions, and platform customization solutions. E-Monee serves maritime industry, retailers, restaurants, government agencies, convenience stores, grocery stores, pharmacies, travel, entertainment, and healthcare industries. E-Monee.com, Inc was founded in 2000 and is based in Fort Lauderdale, Florida.
Full EMNC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.